Pyrazolam
Pyrazolam is a designer triazolobenzodiazepine structurally related to alprazolam and bromazepam. It is primarily anxiolytic with comparatively little sedation or euphoria, and is notable for not being metabolised into other active benzodiazepines. Sold as a research chemical, it still carries benzodiazepine dependence risk and dangerous additive respiratory depression with opioids or alcohol.
01 Overview
Pyrazolam appeared on the research-chemical market around 2012. It has no clinical development history; available information comes from analytical chemistry and a limited number of self-experiment and forensic reports. It is reported to be excreted largely unchanged, which distinguishes it from many other benzodiazepines that produce active metabolites.
Users describe it as a relatively 'clean' anxiolytic with weaker sedative and recreational effects than alprazolam. That profile can encourage frequent daytime dosing, which still produces tolerance and dependence over time. As with all designer benzodiazepines, milligram potency and unregulated purity make accurate dosing and combination safety the central concerns.
02 Mechanism
Positive allosteric modulation of the GABA-A receptor at the benzodiazepine site; the triazole ring confers high potency and relative selectivity for anxiolysis.
03 Dosing
| Tier | Dose | Route | Notes |
|---|---|---|---|
| Threshold | 0.25–0.5 mg | Oral | Comparable potency to alprazolam. |
| Common | 0.5–1 mg | Oral | Primarily anxiolytic; less sedation than alprazolam. |
| Strong | 1–1.5 mg | Oral | More pronounced sedation and impairment. |
04 Effects
| Effect | Magnitude | Evidence | |
|---|---|---|---|
| AnxiolysisMarked anxiety reduction with relatively little sedation. | strong | Anecdotal | |
| Mild sedationLess pronounced drowsiness than most benzodiazepines. | mild | Anecdotal | |
| Muscle relaxationSome reduction in muscle tension. | mild-moderate | Anecdotal |
05 Side effects
| Effect | Severity | Frequency | Evidence | Countermeasures |
|---|---|---|---|---|
| Dependence and withdrawalTolerance and physical dependence develop; withdrawal can include seizures. | Severe | Common with regular use | Observational | |
| Additive respiratory depressionFatal respiratory suppression possible with opioids or alcohol. | Life-threatening | Uncommon but potentially fatal | Observational | |
| Cognitive and memory impairmentReduced concentration and short-term memory during intoxication. | Moderate | Common | Anecdotal |